| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021791 |
| Receipt No. | R000025132 |
| Official scientific title of the study | Patch test of skin external preparations. |
| Date of disclosure of the study information | 2016/04/07 |
| Last modified on | 2016/04/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Patch test of skin external preparations. | |
| Title of the study (Brief title) | Patch test of skin external preparations. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the primary skin irritation of the skin external preparations. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin reactions immediately, 1day, and 7days after 48h skin external preparations patch. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 48h-closed patch of 6 kinds of skin external preparations on the inner upper arm. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Healthy men and women. | |||
| Key exclusion criteria | -The person who has medical treatment.
-The person who has any allergies. -The person who has an experience of allergy by any drugs or cosmetics. -Pregnant woman or suspicion of pregnancy. -The person who has extensive eczema or sores in their test area (inner upper arm). -The person who judged as unfit for this test by P.I. or the parties concerned. |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Shoichiro Yano |
| Organization | Yaesu Nihonbashi Skin Clinic |
| Division name | Director |
| Address | 1-5-17, Yaesu, Chuo-ku, Tokyo, 103-0028, JAPAN |
| TEL | 03-6202-1200 |
| yanosyo-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Shoichiro Yano |
| Organization | Yaesu Nihonbashi Skin Clinic |
| Division name | Director |
| Address | 1-5-17, Yaesu, Chuo-ku, Tokyo, 103-0028, JAPAN |
| TEL | 03-6202-1200 |
| Homepage URL | |
| yanosyo-tky@umin.ac.jp | |
| Sponsor | |
| Institute | Yaesu Nihonbashi Skin Clinic |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | やえす日本橋ヒフ科(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025132 |